KIT and neoplasm: Based on the interpolated concentration of tumor-bound Db-FM (Fig. 5F, G), CD117 Db-FM displayed higher MFIs (consistent with the antigen expression levels), with on-tumor concentrations starting at 4.4 nM 1 h after injection, with a 3-fold decrease observed between 1 and 6 h post-injection.